LOVACARD (Mevacor)20 mg – 100 tablet

LOVACARD (Mevacor)20 mg – 100 tablet

$44.27

Each Lovacard contains 20 mg Lovastatin 100 tablets. Used to prevent heart attacks, lower bad cholesterol and raise good cholesterol (HDL)

ATC Classification: C10AA02
Active Ingrediant: Lovastatin
Generic Name: LOVACARD
Manufacturer: Cipla Limited
Strength: 20 mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 Tab

Description

Lovastatin Information

Pronunciation

LOE va sta tin

What is this drug used for?

• It is used to slow the progress of heart disease.

• It is used to prevent heart attacks.

• It is used to prevent chest pain.

• It is used to lower bad cholesterol and raise good cholesterol (HDL).

• It is used to lower triglycerides.

• It may be given to you for other reasons. Talk with the doctor.

Frequently reported side effects of this drug

• Headache

• Back pain

• Flu-like symptoms

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Liver problems like dark urine, fatigue, lack of appetite, nausea, abdominal pain, light-colored stools, vomiting, or yellow skin.

• Unable to pass urine

• Change in amount of urine passed

• Muscle pain

• Muscle tenderness

• Muscle weakness

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Medication Safety Issues

Sound-alike/look-alike issues:

Lovastatin may be confused with atorvaSTATin, Leustatin, Livostin, Lotensin, nystatin, pitavastatin

Mevacor may be confused with Benicar, Lipitor

International issues:

Lovacol [Chile and Finland] may be confused with Levatol brand name for penbutolol [U.S.]

Lovastin [Malaysia, Poland, and Singapore] may be confused with Livostin brand name for levocabastine [multiple international markets]

Mevacor [US, Canada, and multiple international markets] may be confused with Mivacron brand name for mivacurium [multiple international markets]

Storage and Stability

Tablet, immediate release: Store at 20°C to 25°C (68°F to 77°F). Protect from light

Tablet, extended release: Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Avoid excessive heat and humidity.

Adverse Reactions

Adverse reactions reported with immediate release tablets; similar adverse reactions seen with extended release tablets.

Central nervous system: Dizziness, headache

Dermatologic: Skin rash

Gastrointestinal: Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, nausea

Neuromuscular & skeletal: Increased creatine phosphokinase (>2x normal), muscle cramps, myalgia, weakness

Ophthalmic: Blurred vision

Rare but important or life-threatening: Acid regurgitation, alopecia, amnesia (reversible), arthralgia, chest pain, cognitive dysfunction (reversible), cystitis (interstitial; Huang 2015), dermatomyositis, diabetes mellitus (new-onset), elevated glycosylated hemoglobin (HbA1c), eye irritation, increased blood glucose, insomnia, interstitial pulmonary disease, leg pain, memory impairment (reversible), paresthesia, pruritus, reversible confusional state, vomiting, xerostomia

Brand

Cipla

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Shipping From

Reviews

There are no reviews yet.

Be the first to review “LOVACARD (Mevacor)20 mg – 100 tablet”

Your email address will not be published.